Global /South Korea /Healthcare /Drug Manufacturers - General /334970

Prestige Biologics Co., Ltd.

334970

• KRX: 334970 • Delayed

2,400KRW 0.4%

1.58 USD

As of 14 June 2026, Prestige Biologics Co., Ltd. has a market cap of $121.68M USD, ranking #24177 globally and #1104 in South Korea. It ranks #2163 in the Healthcare sector, and #784 in the Drug Manufacturers - General industry.

Global Rank

24177

Country Rank

1104

Sector Rank

2163

Industry Rank

784

Key Stats

Market Cap

$121.68MUSD

185.05B KRW

Enterprise Value

$176.79MUSD

268.41B KRW

Revenue (TTM)

$12.65MUSD

19.24B KRW

EBITDA (TTM)

-$13.43MUSD

-20.39B KRW

Net Income (TTM)

-$18.57MUSD

-28.23B KRW

EBITDA Margin

-106%

Profit Margin

-147%

PS Ratio

9.6

PB Ratio

1.6

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

Founded

2015

Website

prestigebiologics.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.4%	-4%	-3%	-20%	-23%	-21%	-42%	-46%	-86%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	334970 프레스티지바이오로직스 ISIN: KR7334970001 Shares Out.: Shares Outstanding: 77.753M¹ Shares Float: 30.918M² TV: TradingView: KRX: 334970 SA: Stock Analysis: KRX: 334970 YF: Yahoo Finance: 334970.KS GF: Google Finance: KRX: 334970 BA: Barron's: 334970 MS: Morningstar: XKRX: 334970	2,400 KRW	TV: TradingView: KRX: 334970 SA: Stock Analysis: KRX: 334970 YF: Yahoo Finance: 334970.KS GF: Google Finance: KRX: 334970 BA: Barron's: 334970 MS: Morningstar: XKRX: 334970

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Prestige Biologics Co., Ltd.

Prestige Biologics Co., Ltd. operates as a biopharmaceutical company in South Korea. The company offers budget finding, contract development, contract manufacturing, contract packaging, and analytical testing services. It also provides customized engineering solutions for manufacturing process under the ALITA Smart BioFactory brand name. Prestige Biologics Co., Ltd. was formerly known as PrestigeBio Pharmaceuticals and changed its name to Prestige Biologics Co., Ltd. in October 2019. The company was incorporated in 2015 and is based in Cheongju-Si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 7K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 5K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 4K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 4K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 4K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 4K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 626K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 450K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 296K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 264K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 237K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 226K%	20.5	Switzerland

chevron_leftBack